MDH shares in this space, through GovDelivery bulletins and, as appropriate, via State Register announcements, information related to the Prescription Drug Price Transparency Act's implementation and opportunities for public feedback.
Stakeholders interested in receiving announcements on implementation of the act may subscribe to Prescription Drug Price Transparency updates.
Register to report Rx data at MDH
December 4, 2023
New requirements to register with MDH's online reporting system under the Prescription Drug Price Transparency Act (MS 62J.84) goes into effect January 1, 2024, and will apply to all manufactures, Pharmacy Benefit Managers (PBMs), pharmacies, and wholesalers licensed in Minnesota. Some manufacturers may already be registered to report on new and price growth drugs.
Registration is newly opened to wholesalers, pharmacies, and PBMs. Reporting entities may access the online system to register at https://rxpt.health.mn.gov/. View MDH's Registration and Account Management Guide (PDF).
Updated Draft Reporting Guidance Available for Public Comment
November 17, 2023
MDH has released updated draft reporting guidance (PDF) on Prescription Drug Price Transparency for public comment. Stakeholders may submit comment by emailing health.Rx@state.mn.us by 4:30 p.m. CT on Friday, December 8, 2023.
Updates include new reporting on Drugs of Substantial Public Interest and modified registration requirements under 62J.84 (Laws of Minnesota 2023, Chapter 70, Article 2, Sections 8-21, 43). Technical fixes to the original legislation were integrated into the Form and Manner guidance in August of 2023.
Friday, December 8, 2023, at 4:30 p.m. CT
Please email written feedback to health.Rx@state.mn.us
November 9, 2023
The Minnesota Department of Health (MDH) has released new data contained in online data dashboards and downloadable files for the Minnesota Prescription Drug Price Transparency initiative. Access the interactive dashboards and downloadable files.
MDH previews implementation timeline for expanded prescription drug price transparency reporting
October 16, 2023
MDH shared the implementation timeline for expanded prescription drug price transparency reporting on drugs of significant public interest and ways to stay connected.
Updated reporting guidance released
Update on August 1, 2023
MDH has released updated reporting guidance addressing technical fixes to existing manufacturer reporting.
Updates to Rx Price Transparency Reporting After the 2023 Legislative Session
Update on June 13, 2023
As a result of the Minnesota Legislature’s 2023 Session, there are several upcoming changes to Minnesota’s Prescription Drug Price Transparency reporting. The Minnesota Department of Health (MDH) recently announced an upcoming opportunity to provide comment on draft updated reporting requirements under the original Price Transparency legislation. See MDH’s full announcement here.
MDH publishes inaugural batch of prescription drug list prices and report
Update on February 21, 2023
The Minnesota Department of Health (MDH) has released its first legislative report, data dashboards, and downloadable files for the Minnesota Prescription Drug Price Transparency initiative. View the Rx Legislative report Feb 2023 (PDF) and access the interactive dashboards and downloadable files.